Pages that link to "Q416545"
Jump to navigation
Jump to search
The following pages link to asenapine (Q416545):
Displayed 48 items.
- psychosis (Q170082) (← links)
- schizoaffective disorder (Q834047) (← links)
- 5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole (Q27139471) (← links)
- Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview (Q28077687) (← links)
- Asenapine: a clinical review of a second-generation antipsychotic (Q28264149) (← links)
- Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects (Q33894135) (← links)
- Asenapine: a synthesis of efficacy data in bipolar mania and schizophrenia (Q34105769) (← links)
- Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses (Q34292519) (← links)
- Combination therapy for manic phases: a critical review of a common practice (Q34308027) (← links)
- Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics (Q34628304) (← links)
- Asenapine in bipolar disorder: efficacy, safety and place in clinical practice (Q34639548) (← links)
- Iloperidone, asenapine and lurasidone: a primer on their current status (Q34641024) (← links)
- Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis (Q34641561) (← links)
- Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration (Q37012177) (← links)
- Interactions between antiepileptics and second-generation antipsychotics. (Q37983921) (← links)
- The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania. (Q38057380) (← links)
- Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia (Q42057470) (← links)
- Stability-indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation. (Q42214706) (← links)
- Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine (Q42383217) (← links)
- Asenapine for elderly bipolar manic patients. (Q42662661) (← links)
- Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia (Q45712306) (← links)
- Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow (Q48643283) (← links)
- Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension (Q48774724) (← links)
- Asenapine: a new antipsychotic option (Q48788366) (← links)
- Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis (Q49050976) (← links)
- Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study. (Q50763649) (← links)
- A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) (Q61936009) (← links)
- 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) (Q61936353) (← links)
- Asenapine in the Treatment of Older Adults With Bipolar Disorder (Q61965715) (← links)
- Investigator Initiated Study - Asenapine Early Psychosis (Q61975534) (← links)
- Once-Daily Asenapine for Schizophrenia (Q63316250) (← links)
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) (Q63318336) (← links)
- Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307) (Q63319332) (← links)
- Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898) (Q63335021) (← links)
- Development and validation of automated SPE-HPLC-MS/MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine (Q83464974) (← links)
- Valproate reduces the glucuronidation of asenapine without affecting asenapine plasma concentrations (Q84236095) (← links)
- ▼Asenapine for bipolar I disorder? (Q84381509) (← links)
- (Q113434468) (redirect page) (← links)
- User:Magnus Manske/Mix'n'match report/162 (← links | edit)
- Wikidata:Database reports/Constraint violations/P486 (← links | edit)
- Wikidata:Database reports/Constraint violations/P231 (← links | edit)
- Wikidata:Database reports/Constraint violations/P661 (← links | edit)
- Wikidata:Database reports/Constraint violations/P683 (← links | edit)
- Wikidata:Database reports/Constraint violations/P715 (← links | edit)
- Wikidata:Database reports/Constraint violations/P2176 (← links | edit)
- Wikidata:Database reports/Constraint violations/P2275 (← links | edit)
- Wikidata:Database reports/Constraint violations/P3345 (← links | edit)
- Wikidata:Database reports/Constraint violations/P7830 (← links | edit)